Business Context and Reporting Period
Company: Conduent Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 16, 2017
Reporting Period: Fourth Quarter 2016 (Fiscal Year Ended December 31, 2016)
Key Financial Metrics and Charges
The filing discloses two significant non-recurring charges impacting Q4 2016 results:
- Health Enterprise Platform Project Charge:
- Total Pre-tax Charge: Approximately $161 million.
- After-tax Impact: Approximately $98 million ($0.48 per share).
- Composition: Includes $115 million in non-cash write-offs (receivables and asset impairments) and remaining cash outflows for wind-down costs in future quarters.
- Goodwill Impairment Charge:
- Total Pre-tax Charge: Approximately $935 million.
- After-tax Impact: Approximately $828 million ($4.08 per share).
- Reporting Unit: Commercial Sector.
- Cash Impact: None (non-cash charge).
- Remaining Goodwill: Approximately $908 million in the Commercial Sector post-impairment.
Note: The filing does not provide total revenue, net income, operating cash flow, or debt figures for the period, focusing solely on these specific impairment and project charges.
Material Changes and Drivers
Health Enterprise Project: Conduent is in discussions with the State of New York regarding the Health Enterprise platform. The company now believes it is probable that the project will not be fully completed, necessitating the $161 million charge for asset impairments and wind-down costs.
Commercial Sector Performance: The $935 million goodwill impairment is primarily attributable to weaker-than-expected revenues and operating profits in the Commercial Sector, including performance in the fourth quarter of 2016.
Outlook, Risks, and Management Commentary
Future Cash Flows: While the goodwill impairment is non-cash, the Health Enterprise project charge includes cash outflows expected in future quarters for wind-down activities.
Risk Factors: Management highlights several risks that could cause actual results to differ from forward-looking statements, including:
- Changes in government regulation and economic conditions.
- Competitive pressures and pricing challenges.
- Loss or failure of significant clients.
- Ability to estimate contract scope and costs accurately.
- Compliance with laws regarding personal health and financial information.
- Interruptions in telephone and data services.
Investor Verification Checklist
- Verify the specific timeline and remaining cash obligations for the New York Health Enterprise project wind-down.
- Review the Commercial Sector's revenue and profit trends to understand the drivers behind the $935 million goodwill impairment.
- Confirm the status of the remaining $908 million goodwill balance in the Commercial Sector.
- Assess the impact of the $0.48 per share project charge and $4.08 per share impairment charge on the company's overall 2016 earnings per share.
- Monitor future filings for updates on the State of New York discussions and any further contract modifications.